These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32838558)

  • 21. A Comparison of the Quality of Informed Consent for Clinical Trials of an Experimental Hookworm Vaccine Conducted in Developed and Developing Countries.
    Diemert DJ; Lobato L; Styczynski A; Zumer M; Soares A; Gazzinelli MF
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005327. PubMed ID: 28114401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehension of informed consent and voluntary participation in registration cohorts for phase IIb HIV vaccine trial in Dar Es Salaam, Tanzania: a qualitative descriptive study.
    Iseselo MK; Tarimo EAM
    BMC Med Ethics; 2024 Mar; 25(1):29. PubMed ID: 38481301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of an educational video during informed consent in an HIV clinical trial in Haiti.
    Joseph P; Schackman BR; Horwitz R; Nerette S; Verdier RI; Dorsainvil D; Theodore H; Ascensio M; Henrys K; Wright PF; Johnson W; Pape JW; Fitzgerald DW
    J Acquir Immune Defic Syndr; 2006 Aug; 42(5):588-91. PubMed ID: 16837867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contextualizing willingness to participate: recommendations for engagement, recruitment & enrolment of Kenyan MSM in future HIV prevention trials.
    Doshi M; Avery L; Kaddu RP; Gichuhi M; Gakii G; du Plessis E; Dutta S; Khan S; Kimani J; Lorway RR
    BMC Public Health; 2017 May; 17(1):469. PubMed ID: 28521748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishing HIV treatment as prevention in the HIV Prevention Trials Network 052 randomized trial: an ethical odyssey.
    Cohen MS; McCauley M; Sugarman J
    Clin Trials; 2012 Jun; 9(3):340-7. PubMed ID: 22692805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Participant views and experiences of participating in HIV research in sub-Saharan Africa: a qualitative systematic review.
    Nalubega S; Evans C
    JBI Database System Rev Implement Rep; 2015 Jun; 13(5):330-420. PubMed ID: 26455613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experiences in conducting multiple community-based HIV prevention trials among women in KwaZulu-Natal, South Africa.
    Ramjee G; Coumi N; Dladla-Qwabe N; Ganesh S; Gappoo S; Govinden R; Guddera V; Maharaj R; Moodley J; Morar N; Naidoo S; Palanee T
    AIDS Res Ther; 2010 Apr; 7():10. PubMed ID: 20416063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Informed consent to HIV cure research.
    Bromwich D; Millum JR
    J Med Ethics; 2017 Feb; 43(2):108-113. PubMed ID: 27288096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase 1 trial evaluating safety and pharmacokinetics of HIV-1 broadly neutralizing mAbs 10E8VLS and VRC07-523LS.
    Awan SF; Pegu A; Strom L; Carter CA; Hendel CS; Holman LA; Costner PJ; Trofymenko O; Dyer R; Gordon IJ; Rothwell RSS; Hickman SP; Conan-Cibotti M; Doria-Rose NA; Lin BC; O'Connell S; Narpala SR; Almasri CG; Liu C; Ko S; Kwon YD; Namboodiri AM; Pandey JP; Arnold FJ; Carlton K; Gall JG; Kwong PD; Capparelli EV; Bailer RT; McDermott AB; Chen GL; Koup RA; Mascola JR; Coates EE; Ledgerwood JE; Gaudinski MR;
    JCI Insight; 2024 Apr; 9(7):. PubMed ID: 38587079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory Antibodies.
    Zhang Z; Li S; Gu Y; Xia N
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Equitable treatment for HIV/AIDS clinical trial participants: a focus group study of patients, clinician researchers, and administrators in Western Kenya.
    Shaffer DN; Yebei VN; Ballidawa JB; Sidle JE; Greene JY; Meslin EM; Kimaiyo SJ; Tierney WM
    J Med Ethics; 2006 Jan; 32(1):55-60. PubMed ID: 16373525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The Ditrame (ANRS 049) clinical trial aimed at reducing the mother-child transmission of HIV in Abidjan. Participants' understanding of the trial principles].
    Coulibaly-Traoré D; Msellati P; Vidal L; Ekra CW; Dabis F
    Presse Med; 2003 Mar; 32(8):343-50. PubMed ID: 12712680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Standardized metrics can reveal region-specific opportunities in community engagement to aid recruitment in HIV prevention trials.
    Broder GB; Lucas JP; Davis J; Wallace SE; Luthuli N; Baepanye K; White RR; Bolton M; Blanchette C; Andrasik MP
    PLoS One; 2020; 15(9):e0239276. PubMed ID: 32941520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Considerations for designing and implementing combination HIV cure trials: findings from a qualitative in-depth interview study in the United States.
    Dubé K; Kanazawa J; Dee L; Taylor J; Sauceda JA; Gianella S; Smith D; Deeks SG; Peluso MJ
    AIDS Res Ther; 2021 Oct; 18(1):75. PubMed ID: 34663375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergies, tensions and challenges in HIV prevention, treatment and cure research: exploratory conversations with HIV experts in South Africa.
    Moodley K; Rossouw T; Staunton C; Colvin CJ
    BMC Med Ethics; 2016 Apr; 17(1):26. PubMed ID: 27137204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ethical issues in HIV prevention research with people who inject drugs.
    Sugarman J; Rose SM; Metzger D
    Clin Trials; 2014 Apr; 11(2):239-45. PubMed ID: 24127238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Communicating with participants during the conduct of multi-center clinical trials.
    Augustine EF; Dorsey ER; Hauser RA; Elm JJ; Tilley BC; Kieburtz KK
    Clin Trials; 2016 Dec; 13(6):592-596. PubMed ID: 27573636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involving South Asian patients in clinical trials.
    Hussain-Gambles M; Leese B; Atkin K; Brown J; Mason S; Tovey P
    Health Technol Assess; 2004 Oct; 8(42):iii, 1-109. PubMed ID: 15488164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.
    Mayer KH; Seaton KE; Huang Y; Grunenberg N; Isaacs A; Allen M; Ledgerwood JE; Frank I; Sobieszczyk ME; Baden LR; Rodriguez B; Van Tieu H; Tomaras GD; Deal A; Goodman D; Bailer RT; Ferrari G; Jensen R; Hural J; Graham BS; Mascola JR; Corey L; Montefiori DC; ;
    PLoS Med; 2017 Nov; 14(11):e1002435. PubMed ID: 29136037
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.